Literature DB >> 11864322

European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis.

Paul E. Klapper1, Graham M. Cleator.   

Abstract

Entities:  

Year:  1998        PMID： 11864322     DOI： 10.1111/j.1469-0691.1998.tb00665.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

1.  Rapid detection of herpes simplex virus DNA in cerebrospinal fluid: comparison between loop-mediated isothermal amplification and real-time PCR.

Authors:  Hiroshi Kimura; Masaru Ihira; Yoshihiro Enomoto; Jun-ichi Kawada; Yoshinori Ito; Tsuneo Morishima; Tetsushi Yoshikawa; Yoshizo Asano
Journal:  Med Microbiol Immunol       Date:  2005-05-21       Impact factor: 3.402

2.  Elaboration of a clinical and paraclinical score to estimate the probability of herpes simplex virus encephalitis in patients with febrile, acute neurologic impairment.

Authors:  S Gennai; A Rallo; D Keil; A Seigneurin; R Germi; O Epaulard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-17       Impact factor: 3.267

3.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Authors:  A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser
Journal:  Clin Infect Dis       Date:  2013-07-15       Impact factor: 9.079

4.  Implementation and Evaluation of a Fully Automated Multiplex Real-Time PCR Assay on the BD Max Platform to Detect and Differentiate Herpesviridae from Cerebrospinal Fluids.

Authors:  Thomas Köller; Daniel Kurze; Mirjam Lange; Martin Scherdin; Andreas Podbielski; Philipp Warnke
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.